1、 SONG H P, HOU X Q, LI R Y, et al. Atractylenolide I stimulates intestinal epithelial repair through polyamine-mediated Ca(2+) signaling pathway[J]. Phytomedicine, 2017 (28):27-35. SONG H P, HOU X Q, LI R Y, et al. Atractylenolide I stimulates intestinal epithelial repair through polyamine-mediated Ca(2+) signaling pathway[J]. Phytomedicine, 2017 (28):27-35.
2、 FENG H, MCDONOUGH S P, FAN J, et al. Phosphorylatedradix cyathulae officinalis polysaccharides act as adjuvant via promoting dendritic cell maturation[J]. Molecules, 2017, 22(1): 106. FENG H, MCDONOUGH S P, FAN J, et al. Phosphorylatedradix cyathulae officinalis polysaccharides act as adjuvant via promoting dendritic cell maturation[J]. Molecules, 2017, 22(1): 106.
3、 WEI Y, SUI D J, XU H M, et al. Atractylodes lancea rhizome water extract reduces triptolide-induced toxicity and enhances anti-inflammatory effects[J]. Chin J Nat Medicines, 2017, 15(12): 905-911. WEI Y, SUI D J, XU H M, et al. Atractylodes lancea rhizome water extract reduces triptolide-induced toxicity and enhances anti-inflammatory effects[J]. Chin J Nat Medicines, 2017, 15(12): 905-911.
4、 CHEN F, XIE L, KANG R, etal.Gentiopicroside inhibits RANKL-induced osteoclastogenesis by regulating NF-κB and JNK signaling pathways [J]. Biomed Pharmacother,2018(100):142-146. CHEN F, XIE L, KANG R, etal.Gentiopicroside inhibits RANKL-induced osteoclastogenesis by regulating NF-κB and JNK signaling pathways [J]. Biomed Pharmacother,2018(100):142-146.
5、 HUAN Y, XIAO C, YANG Y L,et al. Ramulus cinnamomi extract attenuates neuroinflammatory responses viadownregulating TLR4/MyD88 signaling pathway in BV2 cells[J]. Neural Regen Res, 2017,12(11): 1860-1864. HUAN Y, XIAO C, YANG Y L,et al. Ramulus cinnamomi extract attenuates neuroinflammatory responses viadownregulating TLR4/MyD88 signaling pathway in BV2 cells[J]. Neural Regen Res, 2017,12(11): 1860-1864.
6、 DONG Y, LIU L, SHAN X, et al. Pilose antler peptide attenuates LPS-induced inflammatory reaction [J]. Int J Biol Macromol, 2018(108):272-276. DONG Y, LIU L, SHAN X, et al. Pilose antler peptide attenuates LPS-induced inflammatory reaction [J]. Int J Biol Macromol, 2018(108):272-276.
7、 CHUNHUI Y, WENJUN C, HUI W, et al. Pilose antler peptide protects osteoblasts from inflammatory and oxidative injury through EGF/EGFR signaling[J]. Int J Biol Macromol, 2017(99):15-20. CHUNHUI Y, WENJUN C, HUI W, et al. Pilose antler peptide protects osteoblasts from inflammatory and oxidative injury through EGF/EGFR signaling[J]. Int J Biol Macromol, 2017(99):15-20.
8、 LIU G, MA C, WANG P, et al. Pilose antler peptide potentiates osteoblast differentiation and inhibitsosteoclastogenesis via manipulating the NF-κB pathway [J]. Biochem Biophys Res Commun, 2017, 491(2): 388-395. LIU G, MA C, WANG P, et al. Pilose antler peptide potentiates osteoblast differentiation and inhibitsosteoclastogenesis via manipulating the NF-κB pathway [J]. Biochem Biophys Res Commun, 2017, 491(2): 388-395.
9、 WU F F, LI H Q, JIN L J, et al. Deer antler base as a traditional Chinese medicine: a review of its traditional uses, chemistry and pharmacology [J]. J Ethnopharmacol, 2013, 145(2): 403-415. WU F F, LI H Q, JIN L J, et al. Deer antler base as a traditional Chinese medicine: a review of its traditional uses, chemistry and pharmacology [J]. J Ethnopharmacol, 2013, 145(2): 403-415.
10、 HENRY D, PAGE J, WHYTE I, et al. Consumption of non-steroidal anti-inflammatory drugs and the development of functional renal impairment in elderly subjects. Results of a case-control study [J]. Br J Clin Pharmacol, 1997, 44(1): 85-90. HENRY D, PAGE J, WHYTE I, et al. Consumption of non-steroidal anti-inflammatory drugs and the development of functional renal impairment in elderly subjects. Results of a case-control study [J]. Br J Clin Pharmacol, 1997, 44(1): 85-90.
11、 TRELLE S, REICHENBACH S, WANDEL S, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis[J]. Brit Med J, 2011(342): 154. TRELLE S, REICHENBACH S, WANDEL S, et al. Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis[J]. Brit Med J, 2011(342): 154.
12、 van der HEIJDE D, SIEPER J, MAKSYMOWYCH W P, et al. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis [J]. Ann Rheum Dis, 2011, 70(6): 905-908. van der HEIJDE D, SIEPER J, MAKSYMOWYCH W P, et al. 2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis [J]. Ann Rheum Dis, 2011, 70(6): 905-908.
13、 van der LINDEN S, VALKENBURG H A, CATS A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria [J]. Arthritis Rheum,1984, 27(4): 361-368. van der LINDEN S, VALKENBURG H A, CATS A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria [J]. Arthritis Rheum,1984, 27(4): 361-368.
14、 XU X, WAN Y, GONG L, et al. Chinese herbal medicine Yanghe decoction for knee osteoarthritis: a protocol for systematic review and meta-analysis [J]. Medicine, 2020,99(34):e21877. XU X, WAN Y, GONG L, et al. Chinese herbal medicine Yanghe decoction for knee osteoarthritis: a protocol for systematic review and meta-analysis [J]. Medicine, 2020,99(34):e21877.
15、 WARD M M, DEODHAR A, GENSLER L S, et al. 2019 update of the American College of Rheumatology/Spondylitis Association of America/spondyloarthritis research and treatment network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis [J]. Arthritis Care Res,2019, 71(10):1285-1299. WARD M M, DEODHAR A, GENSLER L S, et al. 2019 update of the American College of Rheumatology/Spondylitis Association of America/spondyloarthritis research and treatment network recommendations for the treatment of ankylosing spondylitis and nonradiographic axial spondyloarthritis [J]. Arthritis Care Res,2019, 71(10):1285-1299.
16、 KILTZ U, LANDEWé R B M, van der HEIJDE D, et al. Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis [J]. Ann Rheum Dis,2020,79(2):193-201. KILTZ U, LANDEWé R B M, van der HEIJDE D, et al. Development of ASAS quality standards to improve the quality of health and care services for patients with axial spondyloarthritis [J]. Ann Rheum Dis,2020,79(2):193-201.
17、 XUAN Y, HUANG H, HUANG Y, et al. The efficacy and safety of simple-needling therapy for treating ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials[J]. Evid Based Complement Altern Med, 2020,2020(6):1-10. XUAN Y, HUANG H, HUANG Y, et al. The efficacy and safety of simple-needling therapy for treating ankylosing spondylitis: a systematic review and meta-analysis of randomized controlled trials[J]. Evid Based Complement Altern Med, 2020,2020(6):1-10.
18、 LIN S S, LIU C X, ZHANG J H, et al. Efficacy and safety of sinomenine preparation for ankylosing spondylitis: a systematic review and meta-analysis of clinical randomized controlled trials[J]. Evid Based Complement Altern Med, 2020,2020(11):1-16. LIN S S, LIU C X, ZHANG J H, et al. Efficacy and safety of sinomenine preparation for ankylosing spondylitis: a systematic review and meta-analysis of clinical randomized controlled trials[J]. Evid Based Complement Altern Med, 2020,2020(11):1-16.
19、 BRAUN J, SIEPER J. JüRGEN BRAUN, SIEPER J. Ankylosing Spondylitis[J]. Lancet, 2007,369(9570):1379-1390. BRAUN J, SIEPER J. JüRGEN BRAUN, SIEPER J. Ankylosing Spondylitis[J]. Lancet, 2007,369(9570):1379-1390.
